-
Published 7/26/2025
Diray-Arce J, Chang AC, Moradipoor S, Amodio D, Carleton B, Chang WC, Crawford NW, Karoly M, Hoch A, McEnaney K, Kafil TS, Donthireddy M, Steltz SK, van Haren SD, Angelidou A, Smolen KK, Steen H, Lasky-Su J, Tran H, Liu P, Creech CB, Cutland CL, Petousis-Harris H, Nazy I, Yeung RSM, Kochhar S, Black S, Wood N, Nordenberg D, Palma P, Ovsyannikova IG, Kennedy RB, Poland GA, Ozonoff A, Chen RT, Levy O, Top KA. Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkers. Vaccine. 2025 Aug 30; 62:127504. PMID: 40716144.
-
Published 6/23/2025
Amodio D, Rossetti C, Angelidou A, Sanna M, Cellini S, Marrero Cabrera MC, Acciaccarelli M, Neri A, Pontrelli G, Roversi M, Carlo Valensise HC, Farsetti D, Thomas S, Hoch A, Syphurs C, Kaur R, Smolen KK, van Haren S, Steen H, Diray-Arce J, Martino D, McEnaney K, Pichichero M, Su JL, Levy O, Palma P. Immune Development in Early Life (IDEaL) longitudinal cohort study protocol: Identifying biomarkers of vaccine responsiveness, respiratory infection, and asthma. J Allergy Clin Immunol Glob. 2025 Nov; 4(4):100517. PMID: 40727648.
-
Published 6/18/2025
Andrews C, Vodapally S, Foster LP, Lawandy I, Murphy M, Castellanos M, Moncada D, Mourao ML, Bhushan B, Berger PK, Fichorova R, Monthé-Drèze C, Freedman SD, Angelidou A, Martin CR, Sen S. Cohort profile: Mother and Infant Metabolome and Microbiome (MIMM) study, a prospective cohort study of mothers and infants in Boston, Massachusetts. BMJ Open. 2025 Jun 18; 15(6):e096957. PMID: 40533202.
-
Published 4/3/2025
Violari A, Otwombe K, Hahn W, Chen S, Josipovic D, Baba V, Angelidou A, Smolen KK, Levy O, Mkhize NN, Woodward Davis AS, Martin TM, Haynes BF, Williams WB, Sagawa ZK, Kublin JG, Polakowski L, Brewinski Isaacs M, Yen C, Tomaras G, Corey L, Janes H, Gray GE. Safety and implementation of phase I randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns. J Clin Invest. 2025 Jun 02; 135(11). PMID: 40178906.
-
Published 2/19/2025
Angelidou A, Koster JA, Sherman AC, McLoughlin C, Lalwani P, Kelly A, Saeed A, McEnaney K, Baden LR, Brogna M, Weitzman ER, Levy S, Dowling DJ, Levy O. Product and trial design considerations on the path towards a vaccine to combat opioid overdose. NPJ Vaccines. 2025 Feb 19; 10(1):35. PMID: 39971929.